Regulus reports mixed results in early-stage trial for polycystic kidney disease
May 21 2021 - 11:51AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Mar 2023 to Mar 2024